drugset / Trial / NCT00309738

Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin

NCT00309738

Phase 3 Completed 355 enrolled Kowa Research Europe
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the efficacy and safety of pitavastatin with that of simvastatin in patients with risk factors for heart disease.

Timeline

Start
2005-09
Primary completion
2006-10
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Pitavastatin Small molecule 4 mg
Comparator Simvastatin Small molecule 40 mg

Indications